Not if any good news is to be released? We are waiting on information about the USA lab/plant they are setting up - surely that will be a SP motivator.
Printable View
A lot of people thought this about Blis too. The question is are people buying the products? In PEB's case tests. Where are the sales from Aussi? Why aren't investors focusing on the sales results from Aussi rather than waiting for the USA to flow through?
I would love this company to succeed! I would like you to make a packet STC. You can take me out for a coffee and a Blis K12 icecream. But until they start selling it is not a sure thing. Not at all.
Should sales flow through I will buy in. Until then it is just a gamble based on potential. Been there done that...
Just stumbled across this which may be of interest:
Cellmid moves closer to royalty revenues in 2H 2013 - Proactive ...
Quote:
Cellmid has a non-exclusive licence agreement with Pacific Edge Biotechnology (NZSX: PEB) for the use of MK technology in their Cxbladder test that is expected to launch in mid-2013.
The test provides a cost effective and non-invasive method to more accurately identify the presence of bladder cancer when compared to current testing methods.
The bladder cancer test has been certified for use in Australasia and Spain, and is CLIA certified for the US market.
The Australasian market is fairly small with 50,000 60,000 tests for bladder cancer completed each year. By comparison, the U.S. market is much larger with approximately 1 million patients and generates 1.8 million tests each year.
The test will cost approximately $550 and assuming a 5% penetration rate within 5 years will generate approximately 90,000 tests per year for a total of $49.5M.
Cellmid will collect milestone payments and royalties of ~1.5% for an annualised return of $743,000 in the fifth year.
Launched in OZ in June--no news yet--that 60 cent resistance is proving to be rather stubborn.
I think we could call it rangebound ATM
........I think we'll see a series of announcements in the coming weeks/ months. I expect the SP to go through the roof accorgdingly.......providing it's all good news of course!!! DONT BE CAUGHT NOT HOLDING THEM is my advice BUT as per usual DYOR!
Relax.
I bought this share at 25 cents, saw it rose to 30 cents, and then fell back to 18 cents! Does not make me happy but that's the market, eager for news on a stock which holds great promise.
From 18 cents, it rose and rose and rose all the way to 75 cents.
Now it is retracing back to maybe 55 cents.
If you are a trader, it's a worry.
If you believe in the story, take the sp movements and gyrations as part of the story!
QUOTE=Balance;394007]Relax.
I bought this share at 25 cents, saw it rose to 30 cents, and then fell back to 18 cents! Does not make me happy but that's the market, eager for news on a stock which holds great promise.
From 18 cents, it rose and rose and rose all the way to 75 cents.
Now it is retracing back to maybe 55 cents.
If you are a trader, it's a worry.
If you believe in the story, take the sp movements and gyrations as part of the story![/QUOTE]
Agree NOT looking good for traders at the moment Balance.....this stock could go anywhere at the moment but definitely looking like it's heading south for the time being? What a P#*&K of a day Ive had in the COMP.....must have gone from about 8th place to dead last I reckon, what with BLIS,WDT, OGC and now PEB in serious negative territory I must be DEAD LAST!! (at least Ive got some REAL money riding on Telecom!)
I would'nt be expecting too much in the way of revenue growth in the next results announcement. The Australasian market is reasonably small, estimated at around $6m potentially and it will take some time to build up. David Darling has already mentioned that they are working on some new deals and that there will be some new announcements this year. These could involve entry into new markets or some US deals. These and the announcement, hopefully, regarding approval to operate in the US is what will likely give the shareprice a boost.
As far as Cxcolorectal goes, I think they are working on some technical stuff around trying to make the test easier for clinicains to use and to also reduce the cost.
Does anyone have an Idea just how much capital it would take to Promote a product in the states.
Maybe it doesnt need promoting,but it would be interesting to know.
Often times good products lose money at first, before starting slow steady growth.
Of course everyone would like to know what would be a good realistic starting point to jump in[some have mentioned low to mid 50s]
Most would agree ATM that the race up to 75 was a bit speculative but where it will settle before news is anyones guess.
We seem to be out of the ''id be cautious about being cautious''phase,but on the other side of the coin,it has only dropped 1 point below the physiological 60.
Not holding but watching with interest
......amazes me how the SP is holding up (just)......looking at the lack of Buy Depth. Dont think I wud be putting my hand up to buy more at the moment?
.......havnt got any of those fancy chart plotter things Moose (except on the boat of course) but I do feel the butterflies stirring the GUTOMETER just over the last couple of days......feeling a bit nervous right now!
There certainly aren't any buyers around! One would have to be stupid to sell at this price, given the prospects.
If it were to continue down the next level of support would be around 40c. Some chart indicators are still heading southward.
Just checked the bollies and has broken through the bottom so my guess is it will drift down.